Naomi Kiyota

educat la: Kobe University

ocupație: cercetător

Series

There is nothing here

Creează o nouă serie

Works

There is nothing here

Creează o nouă lucrare

Articole 95

Dată

Title

Autori

2021-07-09

Sites of invasion of cancer of the external auditory canal predicting oncologic outcomes

Kiyoto Shiga, Ken-Ichi Nibu, Akihiro Homma, Takenori Ogawa, Kenji Okami, Shigeru Hirano, Naomi Kiyota
2020-06-24

Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)

Naomi Kiyota, Robert L Ferris, Toshimitsu Endo, Shunji Takahashi, Maura L. Gillison
2020-07-16

Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan

Shunji Takahashi, Naomi Kiyota
2020-06-01

Ibuprofen gargle for chemo- or Chemoradiotherapy-induced Oral Mucositis: a feasibility study

Takeshi Ioroi, Naomi Kiyota
2019-01-01

Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2)

Naomi Kiyota
2019

A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study)

Shunji Takahashi, Naomi Kiyota
2019-02-21

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

Dirk Van Gestel, Naomi Kiyota
2019-05-11

Pharmacokinetic study of the oral fluorouracil antitumor agent S-1 in patients with impaired renal function

Yutaka Fujiwara, Takamasa Hotta, Kenji Tamura, Hironobu Minami, Naomi Kiyota
2019-04-23

Exploratory analysis of prognostic factors for lenvatinib in radioiodine-refractory differentiated thyroid cancer

Chiaki Suzuki, Naomi Kiyota, Naoki Otsuki, Ken-Ichi Nibu
2019-01-08

Impact of retropharyngeal lymph node dissection in the surgical treatment of hypopharyngeal cancer

Naoki Otsuki, Hirotaka Shinomiya, Ken-Ichi Nibu, Naomi Kiyota
2019-01-12

International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV

Susanne Singer, Eva Hammerlid, Hisham Mehanna, Wei-chu Chie, Kristin Bjordal, Naomi Kiyota, Judith E Raber-Durlacher
2019-01-14

A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer

Shunji Takahashi, Naomi Kiyota
2019-04-01

Controversies in relation to neck management in N0 early oral tongue cancer

Naomi Kiyota
2019-09-25

Control of Lung Metastases and Colon Polyposis with Lenvatinib Therapy in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma and an APC Gene Mutation: A Case Study

Naomi Kiyota
2019-03-19

Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE)

Naomi Kiyota
2019-07-03

Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age

George R Blumenschein, Naomi Kiyota, Maura L. Gillison
2019-07-01

A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition)

Makoto Tahara, Yasushi Shimizu, Shunji Takahashi, Naomi Kiyota
2019-06-13

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial

Ilya Romanov, Barbara Burtness, Ezra E Cohen, Kevin J Harrington, Naomi Kiyota
2019-12-01

Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: supplementary analysis of a phase II trial (JCOG0706S1)

Naomi Kiyota
2018-04-14

Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)

Lori J Wirth, Mouhammed Amir Habra, Naomi Kiyota, Bruce Robinson
2018-05-01

3D Culture Represents Apoptosis Induced by Trastuzumab Better than 2D Monolayer Culture

Naomi Kiyota
2018-05-17

Successful treatment switch from lenvatinib to sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer intolerant to lenvatinib due to severe proteinuria.

Akira Miyauchi, Naomi Kiyota
2018-04-06

Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging

Mitsuhiro Hayashi, Naomi Kiyota, Yasuhiro Fujiwara, Hiroaki Aikawa, Akinobu Hamada
2018-12-01

Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND)

Naomi Kiyota
2018-04-17

Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression

Naomi Kiyota, Everett E Vokes, George R Blumenschein, Maura L. Gillison
2018-06-04

CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer

Naomi Kiyota, George R Blumenschein, Everett E Vokes, Maura L. Gillison
2018-08-18

Role of intensive nutrition support and prophylactic percutaneous endoscopic gastrostomy during concomitant chemoradiotherapy for oropharyngeal cancer

Naomi Kiyota, Ken-Ichi Nibu
2018-09-03

Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin

Yohei Shimono, Naomi Kiyota
2018-04-19

Modified TALK Score for Japanese Patients with Laryngeal and Hypopharyngeal Cancers to Predict the Possibility of Laryngeal Preservation by Concurrent Chemoradiotherapy

Naomi Kiyota
2018-12-04

Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia

Seiji Kakiuchi, Naomi Kiyota
2017-05-22

Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data

Naomi Kiyota
2017-03-01

Lenvatinib for Anaplastic Thyroid Cancer

Naomi Kiyota, Shunji Takahashi

Om - wd:Q49917588

Bun Venit la Inventaire!

the library of your friends and communities

afla mai multe